Submitted by Bruce-Jakobi on Apr 29, 2024
This case really gets you to think about your business ethics. It is obviously not okay, in my opinion, for Mylan Pharmaceutical to sell a product that is a necessity and life-saving for a rediculously high price. On the other hand, from the business perspective, it is not like they can sell their EpiPens for free because they wouldn't make any money off of it. It is all about finding a middle-ground between pleasing the public and making a profit, but there is no conclusive right answer.